Gitelman syndrome
Jump to navigation
Jump to search
Introduction
variant of Bartter's syndrome with hypomagnesemia & hypocalciuria
Genetics
- autosomal recessive
- mutation in the thiazide-sensitive Na+Cl- cotransporter of the distal tubule (SLC12A3)
Clinical manifestations
- patients generally present in late adolescence or early adulthood[4]
- patients are often asymptomatic
- transient periods of muscular weakness & tetany, usually accompanied by abdominal pain, vomiting & fever
- normal blood pressure
- phenotype is highly heterogeneous in terms of age at onset & severity
- laboratory features might also change during life
- overlapping features with Bartter syndrome
Laboratory
- arterial blood gas, serum K+: hypokalemic metabolic alkalosis
- serum magnesium: hypomagnesemia
- serum Ca+2 may be high normal
- urine Ca+2: hypocalciuria
- urine chloride > 20 meq/L[4]
- plasma renin activity increased
- SLC12A3 gene mutation
More general terms
Additional terms
- Bartter syndrome
- hyperaldosteronism
- solute carrier family 12 member 3; thiazide-sensitive Na+Cl- cotransporter; Na+Cl- symporter (SLC12A3, TSC)
References
- ↑ OMIM https://mirror.omim.org/entry/263800
- ↑ UniProt http://www.uniprot.org/uniprot/P55017.html
- ↑ Nakhoul F, Nakhoul N, Dorman E, Berger L, Skorecki K, Magen D. Gitelman's syndrome: a pathophysiological and clinical update. Endocrine. 2012 Feb;41(1):53-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22169961
- ↑ 4.0 4.1 4.2 Medical Knowledge Self Assessment Program (MKSAP) 19. American College of Physicians, Philadelphia 2021
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022